Literature DB >> 21600264

Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.

Matthew Schrag1, Claudius Mueller, Udochukwu Oyoyo, Mark A Smith, Wolff M Kirsch.   

Abstract

Dysfunctional homeostasis of transition metals is believed to play a role in the pathogenesis of Alzheimer's disease (AD). Although questioned by some, brain copper, zinc, and particularly iron overload are widely accepted features of AD which have led to the hypothesis that oxidative stress generated from aberrant homeostasis of these transition metals might be a pathogenic mechanism behind AD. This meta-analysis compiled and critically assessed available quantitative data on brain iron, zinc and copper levels in AD patients compared to aged controls. The results were very heterogeneous. A series of heavily cited articles from one laboratory reported a large increase in iron in AD neocortex compared to age-matched controls (p<0.0001) while seven laboratories failed to reproduce these findings reporting no significant difference between the groups (p=0.76). A more than three-fold citation bias was found to favor outlier studies reporting increases in iron and this bias was particularly prominent among narrative review articles. Additionally, while zinc was not significantly changed in the neocortex (p=0.29), copper was significantly depleted in AD (p=0.0003). In light of these findings, it will be important to re-evaluate the hypothesis that transition metal overload accounts for oxidative injury noted in AD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600264      PMCID: PMC3134620          DOI: 10.1016/j.pneurobio.2011.05.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  85 in total

Review 1.  Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease.

Authors:  George Perry; Marta A Taddeo; Robert B Petersen; Rudy J Castellani; Peggy L R Harris; Sandra L Siedlak; Adam D Cash; Quan Liu; Akohiko Nunomura; Craig S Atwood; Mark A Smith
Journal:  Biometals       Date:  2003-03       Impact factor: 2.949

2.  Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias.

Authors:  Shino Magaki; Ravi Raghavan; Claudius Mueller; Kerby C Oberg; Harry V Vinters; Wolff M Kirsch
Journal:  Neurosci Lett       Date:  2007-03-03       Impact factor: 3.046

3.  Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients.

Authors:  Michael J House; Timothy G St Pierre; Kris V Kowdley; Thomas Montine; James Connor; John Beard; Jose Berger; Narendra Siddaiah; Eric Shankland; Lee-Way Jin
Journal:  Magn Reson Med       Date:  2007-01       Impact factor: 4.668

Review 4.  Metal chelation as a potential therapy for Alzheimer's disease.

Authors:  M P Cuajungco; K Y Fagét; X Huang; R E Tanzi; A I Bush
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.

Authors:  R Squitti; P M Rossini; E Cassetta; F Moffa; P Pasqualetti; M Cortesi; A Colloca; L Rossi; A Finazzi-Agró
Journal:  Eur J Clin Invest       Date:  2002-01       Impact factor: 4.686

6.  Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.

Authors:  D A Loeffler; J R Connor; P L Juneau; B S Snyder; L Kanaley; A J DeMaggio; H Nguyen; C M Brickman; P A LeWitt
Journal:  J Neurochem       Date:  1995-08       Impact factor: 5.372

Review 7.  Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD.

Authors:  Hyman M Schipper; Ajay Gupta; Walter A Szarek
Journal:  Curr Alzheimer Res       Date:  2009-10       Impact factor: 3.498

8.  Trace elements in Alzheimer's disease pituitary glands.

Authors:  C R Cornett; W D Ehmann; D R Wekstein; W R Markesbery
Journal:  Biol Trace Elem Res       Date:  1998 Apr-May       Impact factor: 3.738

9.  Brain Iron and Zinc Contents of German Patients with Alzheimer Disease.

Authors:  Erzsébet Andrási; Eva Farkas; Dieter Gawlik; Ullrich Rösick; Peter Brätter
Journal:  J Alzheimers Dis       Date:  2000-03       Impact factor: 4.472

10.  A systematic comparison of software dedicated to meta-analysis of causal studies.

Authors:  Leon Bax; Ly-Mee Yu; Noriaki Ikeda; Karel G M Moons
Journal:  BMC Med Res Methodol       Date:  2007-09-10       Impact factor: 4.615

View more
  80 in total

1.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Authors:  Steven T Szabo; G Jean Harry; Kathleen M Hayden; David T Szabo; Linda Birnbaum
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

3.  Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.

Authors:  Rosanna Squitti; Mariacarla Ventriglia; Massimo Gennarelli; Nicola A Colabufo; Imane Ghafir El Idrissi; Serena Bucossi; Stefania Mariani; Mauro Rongioletti; Orazio Zanetti; Chiara Congiu; Paolo M Rossini; Cristian Bonvicini
Journal:  Mol Neurobiol       Date:  2016-01-12       Impact factor: 5.590

4.  Genetic predisposition for inflammation exacerbates effects of striatal iron content on cognitive switching ability in healthy aging.

Authors:  Ana M Daugherty; David A Hoagey; Kristen M Kennedy; Karen M Rodrigue
Journal:  Neuroimage       Date:  2018-10-25       Impact factor: 6.556

Review 5.  Environmental and Dietary Exposure to Copper and Its Cellular Mechanisms Linking to Alzheimer's Disease.

Authors:  Heng-Wei Hsu; Stephen C Bondy; Masashi Kitazawa
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

6.  Blood levels of trace metals and amyotrophic lateral sclerosis.

Authors:  Tracy L Peters; John D Beard; David M Umbach; Kelli Allen; Jean Keller; Daniela Mariosa; Dale P Sandler; Silke Schmidt; Fang Fang; Weimin Ye; Freya Kamel
Journal:  Neurotoxicology       Date:  2016-04-13       Impact factor: 4.294

7.  Towards Knowledge Maintenance in Scientific Digital Libraries with the Keystone Framework.

Authors:  Yuanxi Fu; Jodi Schneider
Journal:  Proc ACM/IEEE Joint Conf Digit Libr       Date:  2020-08-01

Review 8.  Alzheimer's silent partner: cerebral amyloid angiopathy.

Authors:  Tanya L Cupino; Matthew K Zabel
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

Review 9.  Opportunities in multidimensional trace metal imaging: taking copper-associated disease research to the next level.

Authors:  Stefan Vogt; Martina Ralle
Journal:  Anal Bioanal Chem       Date:  2012-10-19       Impact factor: 4.142

10.  Zinc and the aging brain.

Authors:  Johnathan R Nuttall; Patricia I Oteiza
Journal:  Genes Nutr       Date:  2013-12-24       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.